FDA makes key decision on Zyn nicotine pouches
In a statement, the FDA said it has authorized the marketing and sale of Philip Morris International’s Zyn nicotine pouches.
PMI's Commitment To Smoke-Free Future: Advancing Better Alternatives, Global Innovations
Stefano Volpetti, President of Smoke-Free Inhalable Products and Consumer Officer at Philip Morris International (PMI), ...
The American Journal of Managed Care19h
In a First-of-Its-Kind Decision, FDA Will Allow Marketing of Nicotine Pouches
This marketing decision from the FDA covers 2 nicotine strengths, 3 mg and 6 mg, and 10 flavors of the small tobacco-free ...
Food companies want to confuse consumers. The FDA must push back.
Food companies criticize the science supporting front-of-package labeling, delay public consultation periods, push for their ...
STAT4h
Three former FDA officials: Here’s what Trump and his nominees need to know
The FDA is the leading science-based consumer protection agency in the world. Three former senior officials write about what ...
JD Supra14h
Trump’s FDA and USDA: Five Key Issues To Watch in 2025
The Trump administration’s food regulatory agenda will come into sharper focus once nominees for the U.S. Department of Health and Human ...
Bloomberg L.P.17h
Philip Morris International Inc
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...